GMAB

Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial

06/02 02:30 pm

Genmab to Submit Supplemental Biologics License Application (sBLA) to U.S. Food and Drug Administration for Epcoritamab Plus Rituximab and Lenalidomide (R2) in Patients with Relapsed/Refractory Follicular Lymphoma (FL)

05/01 08:14 pm

Antibody Discovery Market Size to Achieve USD 22,570 Mn by 2034 | Statifacts

04/11 10:50 am

Genmab to Vigorously Defend Alleged Claims of Trade Secret Misappropriation by AbbVie Inc.

03/21 11:29 pm

Grant of Restricted Stock Units to Management and Employees and Grant of Warrants to Employees in Genmab

02/28 05:00 pm

Genmab to Present at the 43rd Annual J.P. Morgan Healthcare Conference

01/03 02:56 pm

Two Data Analyses from Clinical Trials Show Epcoritamab (DuoBody® CD3xCD20) Induces Durable, Complete Responses as Monotherapy and Combination Treatment in Patients With Diffuse Large B-Cell Lymphoma (DLBCL)

12/09 01:00 pm

CD40 Targeted Therapies Clinical Trials & Market Opportunity Report 2025, Insight By Company, Country, Indication & Phase

12/09 05:48 am

Investigational Epcoritamab (DuoBody® CD3xCD20) Combination Therapy Demonstrates High Response Rates in Clinical Trial of Patients With Relapsed or Refractory (R/R) Follicular Lymphoma (FL)

12/07 08:12 pm

Grant of Restricted Stock Units and Warrants to Employees in Genmab

11/21 03:48 pm

Genmab to Present at Jefferies London Healthcare Conference

11/05 02:11 pm

Down -14.68% in 4 Weeks, Here's Why Genmab Looks Ripe for a Turnaround

10/08 02:06 pm

Investigational Rinatabart Sesutecan (Rina-S) Shows Promising Anti-Tumor Activity as Single Agent in Heavily Pretreated Patients with Ovarian and Endometrial Cancers in Phase 1/2 Clinical Trial

09/15 08:45 am

Genmab to Present at Morgan Stanley 22nd Annual Global Healthcare Conference

08/26 12:26 pm

Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons

08/13 02:53 pm

Capital Increase in Genmab as a Result of Employee Warrant Exercise

08/13 02:51 pm

Should You Buy AbbVie (ABBV) After Q2 Beat, Guidance Raise?

08/01 11:41 am

Genmab Announces Net Sales of DARZALEX® (daratumumab) for Second Quarter of 2024 - GlobeNewswire

07/17 06:26 am

ISS suggest Enhabit shareholders elect three AREX Capital nominees to board By Reuters - Investing.com

07/12 11:42 am

Antibody Drug Conjugates Market Insights 2018-2023 and - GlobeNewswire

07/12 06:40 am

AbbVie (ABBV) Up 24% in a Year: Buy, Sell or Hold the Stock? - Zacks Investment Research

07/11 09:32 am

AbbVie (ABBV) Gets CHMP Nod for Lymphoma Drug's Expanded Use

07/01 08:37 am

AbbVie/Genmab's Epkinly FDA Approval Is A Positive Step, Analyst Says Additional Expansion Opportunities Underway

06/27 01:22 pm

FDA Expands AbbVie's (ABBV) Epkinly Label in Follicular Lymphoma

06/27 11:03 am

What 9 Analyst Ratings Have To Say About Genmab

05/20 11:00 am

Decoding 9 Analyst Evaluations For Genmab

04/30 08:00 am

AbbVie (ABBV) Beats on Q1 Earnings & Sales, Ups '24 EPS View

04/26 12:10 pm

Analyst Ratings For Genmab

03/26 10:00 am

4 Analysts Assess Genmab: What You Need To Know

02/20 11:00 am

Cracking The Code: Understanding Analyst Reviews For Genmab

01/29 08:00 am

What's Going On With Danish Healthcare Firm Genmab Stock?

01/23 02:11 pm

New Strong Buy Stocks for January 17th

01/17 08:06 am

GMAB or TECH: Which Is the Better Value Stock Right Now?

01/09 05:51 pm

Oracle Reports Weak Sales, Joins Kinetik, Lucid Group And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

12/12 06:32 am

HRMY or GMAB: Which Is the Better Value Stock Right Now?

12/07 12:40 pm

AbbVie (ABBV) Lymphoma Drug Gets FDA Breakthrough Therapy Tag

11/28 12:32 pm

9 Analysts Have This to Say About Genmab

11/28 09:00 am

Analyst Expectations for Genmab's Future

11/08 11:00 am

United Airlines, Interactive Brokers And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

10/18 06:05 am

Merus N.V. (MRUS) Soars 5.5%: Is Further Upside Left in the Stock?

10/17 05:00 am

What 13 Analyst Ratings Have To Say About Genmab

10/13 01:00 pm

Expert Ratings for Genmab

09/26 02:00 pm

AbbVie's (ABBV) Epcoritamab Gets Approval in Europe for DLBCL

09/26 10:56 am

Why Shares of Iovance Biotherapeutics Dropped Thursday

09/14 04:36 pm

AstraZeneca's Tagrisso-Chemo Combo Data In Lung Cancer Sets High Bar For Johnson & Johnson's Cancer Drug: Analyst

09/11 02:31 pm

Analyst Expectations for Genmab's Future

09/05 03:00 pm

Why Shares of Zai Lab Limited Were Jumping on Tuesday

09/05 11:16 am

Seagen's (SGEN) Late-Stage Cervical Cancer Study Meets Goals

09/05 09:23 am

Encouraging Data From Seagen/Genmab's Cervical Cancer Study - Tivdak Success Sets Stage For New Indications

09/05 08:53 am

Benzinga's Top Ratings Upgrades, Downgrades For August 24, 2023

08/24 11:00 am